Zelluna Receives Recommendation to Continue Patient Enrollment in ZIMA-101 Trial

Zelluna has announced that its Independent Data Monitoring Committee has recommended the continuation of patient enrollment in its ZIMA-101 clinical trial.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

taiwan-newsFrench12d ago

Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101 - Taiwan News

Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101 Taiwan News

Read full article →

PERSPECTA

PERSPECTA

Zelluna Receives Recommendation to Continue Patient Enrollment in ZIMA-101 Trial

Sources

Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101 - Taiwan News

Related Stories

48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room

Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy

Study Reveals Hidden Arterial Calcification in Young Adults

Two German Airport Workers Die of Malaria Contracted on Flight

PERSPECTA